What is CBT's health score?

CABOT CORP (CBT) has a TradeApes health score of 66 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CBT's estimated fair value?

Based on our 5-year discounted cash flow model, CABOT CORP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CBT undervalued or overvalued?

Our model currently rates CBT as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CBT... Refresh in a moment for the full analysis.

CABOT CORP (CBT)

Materials Undervalued low healthy

$80.88

Updated: 2026-06-06

TradeApes Score

Financial Strength

65 Healthy

Operating Trend

55 Mixed

Relative Value

65 Healthy

Capital Allocation

80 Strong

Risk

80 Strong

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Revenue declining — sales down 5–15% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.